About ASH
Scientific Meetings
HTN Community Outreach
ASH Foundation Overview
Corporate Members
Related Organizations
Position Papers
ASH Home About Hypertension For Proffesionals For Patients HTN Specialist Membership
American Society of Hypertension (ASH) Members Log in
Make text larger
Home » Scientific Meetings » Scientific Awards » ASH Distinguished Scientist Award

ASH Distinguished Scientist Award

One ASH Distinguished Scientist Award is given each year depending on the field to which the award recipient has made his or her contribution. The purpose of the ASH Distinguished Scientist Award is to honor a scientist or physician for outstanding achievements in the field of hypertension. The award recipient receives a framed certificate and a $10,000 honorarium. The awardee is also requested to present a 30-minute lecture during the awards session at the ASH Annual Meeting and will receive complimentary registration and reimbursement for travel expenses and hotel accommodations.

Sponsors who wish to have their candidates nominated for an award must be current ASH members and provide the following information:

Complete name, address, phone, and fax numbers of the nominee
A signed letter of nomination from the sponsor and at least one additional supporting letter. The letters should clearly articulate the major contributions of the nominee to the field of hypertension.
A current curriculum vitae of candidate.

A candidate may be nominated by one or more different individuals within the same year. Previous winners of the ASH Distinguished Scientist Award and members of the ASH Scientific Awards Committee are not eligble for nomination.

The Awards Committee will assess the candidates' overall scientific contributions and their impact on the field of hypertension.

The ASH Distinguished Scientist Award recipient receives an award within one of these five categories:

William Harvey Award
This award is named for scientist William Harvey (1578- 1657) who developed the first accurate account of how the heart and circulatory system operated.

Richard Bright Award
This award is named for Richard Bright, (1789- 1858). Often referred to as the Father of Nephrology, Dr. Bright is well known for his great contributions to the study of the kidney.

Robert Tigerstedt Award
Robert Tigerstedt (1853- 1923) is recognized as an outstanding contributor to both endocrinology and circulation. He is best known for his discovery of the renin- angiotensin system.

Harriet Dustan Award
This award is named for Harriet P. Dustan, MD (1920 - 1999). Dr. Dustan made many contributions to hypertension in her career of over 40 years. These include her clinical and investigative achievements, especially the concept of essential hypertension as a multifactoral disease of pressure regulation. Dr. Dustan explored many of the pressor mechanisms and related new knowledge to therapeutic concepts.

Irvine Page Award
This award is named for Irvine H. Page, MD (1901 - 1991). In Dr. Page's long research career he made endless discoveries and contributions to the treatment and espousal of hypertension. He may be bast known for the discovery and characterization of angiotensin, the identification of serotonin, and the mosaic theory.

For more information, please contact:
Ashley Buron, Program Coordinator
American Society of Hypertension
45 Main Street, suite #712
Brooklyn, NY 11201
Phone: 212.696.9099
Fax: 347.916.0267
E-mail: awards@ash-us.org

2013 ASH Distinguished Scientist Award

The American Society of Hypertension announced the recipient of the ASH Robert Tigerstedt Award, Ernesto L. Schiffrin, CM, MD, PhD, FRSC, FRCPC, FACP. The 2013 Award was presented during the ASH Twenty-Eigth Annual Scientific Meeting during the Awards Plenary Session, which was held on Friday, May 17, 2013.

Ernesto L. Schiffrin, CM, MD, PhD, FRSC, FRCPC, FACP
Sir Mortimer B. Davis-Jewish General Hospital
Montreal, Canada

Dr. Ernesto Schiffrin was born in Buenos Aires, Argentina. He obtained his MD in 1970 at the University of Buenos Aires, trained in Internal Medicine and hypertension research, and in 1976 moved to Montreal, where he obtained his PhD at McGill University in 1980 working under Roger Boucher and Jacques Genest at the Clinical Research Institute of Montreal (IRCM). He was Professor of Medicine at the University of Montreal, Director of the MRCC (later CIHR) Multidisciplinary Hypertension Group and the Hypertension Clinic at the IRCM, and Internist at Hôtel-Dieu hospital of the Centre Hospitalier de l'Université de Montréal (CHUM) until 2005. Since 2006 he is Physician-in-Chief of the Jewish General Hospital and holds a Canada Research Chair in Hypertension and Vascular Research at the Lady Davis Institute for Medical Research. He is Professor and Vice-Chair (Research), Department of Medicine, McGill University.

Dr. Schiffrin's research deals with mechanisms and treatment of high blood pressure, from molecules and cells to humans. He is author of more than 500 peer-reviewed publications, many book chapters and is editor of 2 published books and two books in preparation, on molecular and clinical aspects of vascular disease and hypertension.

Dr. Schiffrin has been President of the Canadian Hypertension Society (1991-92), Chair of the High Blood Pressure Research Council of the American Heart Association (2002-2004), President of the InterAmerican Society of Hypertension (2005-2007) and President of the Quebec Hypertension Society (2009-2011). Dr. Schiffrin was Vice-President (2010-2012) and is President of the International Society of Hypertension (2012-2014). Dr. Schiffrin is Associate Editor of Hypertension (AHA journal) since 2003.

Dr. Schiffrin received the Young Investigator Award of the Canadian Hypertension Society in 1985, the Senior Investigator Award of the Canadian Society of Internal Medicine in 2003, and the Distinguished Service Award of the Canadian Hypertension Society in 2004. He was elected Fellow of the Royal Society of Canada in 2006, and received the 2007 Irvine Page-Alva Bradley Lifetime Achievement Award of the High Blood Pressure Research Council of the American Heart Association and the 2010 Bjorn Folkow Award of the European Society of Hypertension. He was appointed Member of the Order of Canada (C.M.) in July 2010. He was awarded the 2011 Excellence Award in Hypertension Research of the American Heart Association, in September 2011. He was awarded a Queen Elizabeth Diamond Jubillee Medal in February 2013.